deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01053390

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

A Phase III Study of New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Sponsor: Affiliated Hospital of Qinghai University

Updated 14 times since 2017 Last updated: Dec 18, 2013 Started: Oct 31, 2009 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Gallbladder Neoplasms and is currently completed. Affiliated Hospital of Qinghai University leads this study, which shows 14 recorded versions since 2009 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshot~Nov 2022 – ~Apr 2023 · 5 months · monthly snapshot~Apr 2023 – ~Nov 2023 · 7 months · monthly snapshot~Nov 2023 – ~Feb 2024 · 3 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 19 months · monthly snapshot

Change History

14 versions recorded
  1. Nov 2024 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Nov 2024 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Feb 2024 — Jul 2024 [monthly]

    Completed PHASE3

  5. Nov 2023 — Feb 2024 [monthly]

    Completed PHASE3

Show 9 earlier versions
  1. Apr 2023 — Nov 2023 [monthly]

    Completed PHASE3

  2. Nov 2022 — Apr 2023 [monthly]

    Completed PHASE3

  3. Jan 2021 — Nov 2022 [monthly]

    Completed PHASE3

  4. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE3

  5. Sep 2020 — Nov 2020 [monthly]

    Completed PHASE3

  6. Jun 2018 — Sep 2020 [monthly]

    Completed PHASE3

  7. Jun 2017 — Jun 2018 [monthly]

    Completed PHASE3

  8. May 2017 — Jun 2017 [monthly]

    Completed PHASE3

  9. Jan 2017 — May 2017 [monthly]

    Completed PHASE3

    First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Affiliated Hospital of Qinghai University
  • Air Force Military Medical University, China
  • Capital Medical University
  • China Medical University, China
  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
  • Eastern Hepatobiliary Surgery Hospital
  • First Affiliated Hospital of Chongqing Medical University
  • First Affiliated Hospital of Kunming Medical University
  • First People's Hospital of Kunming
  • Jilin University
  • Lanzhou University Second Hospital
  • Peking University First Hospital
  • Qilu Hospital of Shandong University
  • Qinghai People's Hospital
  • Shandong Provincial Hospital
  • Shanghai Changzheng Hospital
  • Shanghai Jiao Tong University School of Medicine
  • Shengjing Hospital
  • Southwest Hospital, China
  • Tang-Du Hospital
  • The First Affiliated Hospital of Dalian Medical University
  • The Second Affiliated Hospital of Harbin Medical University
  • The first clinical college of harbin medical university
  • The first people's hospital of Guiyang
  • The people's hospital of Heilongjiang province
  • Tianjin Medical University Cancer Institute and Hospital
  • Xi'an Central Hospital
  • Xuanwu Hospital, Beijing
Data source: Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations